Human embryonic stem cells could provide a valuable source or replacement neurons to ameliorate the effects of neural disorders such as Parkinson's disease, but the majority of such cells do not differentiate into specific neuron subtypes when grafted into the adult central nervous system. In November 11 advanced online
Wu et al. treated primary fetal human neural stem cells (hNSCs) with tropic factors or other chemicals important in the development of cholinergic neurons. They observed that after this procedure, mitogen-expanded hNSCs were transformed almost exclusively into neurons when grafted into adult rat CNS. In addition, they showed that a large number of...